THE STATE GIVETH AND THE STATE TAKETH AWAY: SUPPORTING THE RESEARCH‐BASED PHARMACEUTICAL INDUSTRY IN EUROPE AND THE UK

Mike Sedgley

Economic Affairs, 2006, vol. 26, issue 3, 39-47

Abstract: The European research‐based pharmaceutical industry has been declining relative to its US counterpart for more than a decade. It remains a substantial and successful industry, and the UK continues to be a particular success story, but many challenges lie ahead in an increasingly competitive global environment. Recent attempts to reinvigorate and support pharmaceutical and biotech research and development have been numerous, and in the UK now include the R&D tax credit. But it is the operating environment and the structure of the market for pharmaceuticals that represent the biggest challenges for the industry and policy‐makers.

Date: 2006
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1111/j.1468-0270.2006.00648.x

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:ecaffa:v:26:y:2006:i:3:p:39-47

Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=0265-0665

Access Statistics for this article

Economic Affairs is currently edited by Philip Booth

More articles in Economic Affairs from Wiley Blackwell
Bibliographic data for series maintained by Wiley Content Delivery ().